Molecular Formula | C19H19F2N7O |
Molar Mass | 399.4 |
Melting Point | 196-198°C |
Solubility | DMSO: ≥20mg/mL |
Appearance | powder |
Color | white to off-white |
Storage Condition | Store at +4°C |
In vivo study | L-838417 (1.0 mg/kg) produces anxiolytic effects in adult rat, as indexed by a transformation of social avoidance into preference and an increase in social investigation. L-838417 (2.0 mg/kg) eliminates social avoidance, but has no anxiolytic effects on social investigation. L-838417 (0.5 mg/kg) reverses the anxiogenic effects of prior stress regardless of age, but with doses ≥ 1 mg/kg decreases social investigation, an effect possibly due in part to locomotor-impairing effects of this compound. Animal Model: Male and female adolescent and adult Sprague–Dawley rats. Dosage: 0, 0.5, 1.0, 2.0, or 4.0 mg/kg. Administration: IP. Result: Adolescents required a higher dose (2 mg/kg) to attenuate their social avoidance. The lowest dose of 0.5 mg/kg was sufficient to reverse the anxiogenic effects of repeated restraint as reflected by a significant increase in the coefficient relative to vehicle-treated animals. |
WGK Germany | 3 |